课题基金 / 基金详情

Effect of HB-EGF on liver regeneration in vovo and its application as a therapeutic agent.

Effect of HB-EGF on liver regeneration in vovo and its application as a therapeutic agent.
HB-EGF 对体内肝再生的影响及其作为治疗剂的应用。
批准号:
09670544
负责人:
TAMURA Shinji
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

TAMURA Shinji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have reported that heparin-binding EGF-like growth factor(HB-EGF) is a potent mitogen of hepatocytes in vitro.The level of HB -EGF mRNA in regenerating rat liver increases rapidly after a partial hepatectomy.In vitro study showed that HB-EGF induces the expression of HGF and TGF-alpha in non-parenchymal cells and hepatocytes, respectively.These results indicated that HB-EGF may play an important role in liver regeneration.In this study, we investigated the plasma HB-EGF levels in patients after partial hepatectomy using enzyme-linked immunosorbent assay.In patients who underwent gross hepatectomy, plasma HB-EGF levels increased, reaching maximal levels approximately 5 to 7 days after surgery, which indicated that HB-EGF may be involved in liver regeneration in human.We also investigated the effect of administration HB-EGF to mice on proliferation of hepatocyte in vivo.Recombinant HB-EGF were administered intravenously to the normal mice for 4 times at 2h-interval.Proliferation of hepatocyte were determined as labeling index of BrdU.Activation of NE-kB and STAT-3 were studied using gel shift assay.The labeling index is 300-fold higher in HB-EGF administered mice than that of controls.In vivo administration of HB-EGF activated NF-kB and STAT-3 in the liver. The induction of HGF were observed in HB-EGF-administered mice liver.In summary, in vivo administration of HB-EGF stimulated liver regeneration in normal mice liver, which indicated that HB-EGF could be a therapeutic agent for liver regeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
山田 晃: "ヒト肝切除術後の血中Heparin-Binding EGF-Like Growth Factor(HB-EGF)の動態" Minophagen Medical Review. 42・5. 273-274 (1997)
Akira Yamada:“人体肝切除术后血液中肝素结合 EGF 样生长因子 (HB-EGF) 的动态”Minophagen 医学评论 42・5 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Yamada, et al.: "Plasma heparin-binding EGF-like growth factor levels in patients after partial hepatectomy." Minophagen Medial Review.
S.Yamada 等人:“部分肝切除术后患者的血浆肝素结合 EGF 样生长因子水平。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
河田純男: "肝疾患における増殖因子の作用" 現代医療. 27・6. 1431-1437 (1997)
Sumio Kawata:“生长因子对肝脏疾病的影响”现代医学27・6。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Nagase: "Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but not disturb lamin farnesylation and localization in human tumour cells." British Journal of Cancer. 76・8. 1001-1010 (1997)
T.Nagase:“Manumycin 和胶霉毒素衍生物 KT7595 阻断 Ras 法尼基化和细胞生长,但不干扰人类肿瘤细胞中的核纤层蛋白法尼基化和定位。”英国癌症杂志 76·8 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Control of phase transition of the rare earth oxyfluorides
    • 批准号:
      20K05077
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2020
    • 负责人:
      TAMURA Shinji
    • 依托单位:
    Development of the divalent cation conducting solid electrolytes
    • 批准号:
      24750202
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $3.0万
    • 财政年份:
      2012
    • 负责人:
      TAMURA Shinji
    • 依托单位:
    Studies on High-valent Cation Conducting Solid Electrolytes
    • 批准号:
      21750208
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      TAMURA Shinji
    • 依托单位:
    Evaluation of novel metastasis-related genes and development of an early diagnostic marker in head and neck cancer
    • 批准号:
      21592204
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      TAMURA Shinji
    • 依托单位:
    海外基金